These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16091293)

  • 1. PPARgamma antagonists exacerbate neural antigen-specific Th1 response and experimental allergic encephalomyelitis.
    Raikwar HP; Muthian G; Rajasingh J; Johnson C; Bright JJ
    J Neuroimmunol; 2005 Oct; 167(1-2):99-107. PubMed ID: 16091293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARgamma antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy-Delta12,14-prostaglandin J2.
    Raikwar HP; Muthian G; Rajasingh J; Johnson CN; Bright JJ
    J Neuroimmunol; 2006 Sep; 178(1-2):76-86. PubMed ID: 16844232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor-gamma-deficient heterozygous mice develop an exacerbated neural antigen-induced Th1 response and experimental allergic encephalomyelitis.
    Natarajan C; Muthian G; Barak Y; Evans RM; Bright JJ
    J Immunol; 2003 Dec; 171(11):5743-50. PubMed ID: 14634082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation.
    Natarajan C; Bright JJ
    Genes Immun; 2002 Apr; 3(2):59-70. PubMed ID: 11960303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARδ deficient mice develop elevated Th1/Th17 responses and prolonged experimental autoimmune encephalomyelitis.
    Kanakasabai S; Walline CC; Chakraborty S; Bright JJ
    Brain Res; 2011 Feb; 1376():101-12. PubMed ID: 21192919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis.
    Muthian G; Raikwar HP; Rajasingh J; Bright JJ
    J Neurosci Res; 2006 May; 83(7):1299-309. PubMed ID: 16547967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A chimeric TCR-beta chain confers increased susceptibility to EAE.
    Petersen TR; Lata R; Spittle E; Bäckström BT
    Mol Immunol; 2007 Jul; 44(14):3473-81. PubMed ID: 17481734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of preproenkephalin in experimental autoimmune encephalomyelitis.
    Weir C; McNeill A; Hook S; Harvie M; La Flamme AC; Le Gros G; Bäckström BT
    J Neuroimmunol; 2006 Oct; 179(1-2):18-25. PubMed ID: 16904193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis.
    Feinstein DL; Galea E; Gavrilyuk V; Brosnan CF; Whitacre CC; Dumitrescu-Ozimek L; Landreth GE; Pershadsingh HA; Weinberg G; Heneka MT
    Ann Neurol; 2002 Jun; 51(6):694-702. PubMed ID: 12112074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An interferon-gamma-producing Th1 subset is the major source of IL-17 in experimental autoimmune encephalitis.
    Suryani S; Sutton I
    J Neuroimmunol; 2007 Feb; 183(1-2):96-103. PubMed ID: 17240458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD62L is required for the priming of encephalitogenic T cells but does not play a major role in the effector phase of experimental autoimmune encephalomyelitis.
    Li O; Liu JQ; Zhang H; Zheng P; Liu Y; Bai XF
    Scand J Immunol; 2006 Aug; 64(2):117-24. PubMed ID: 16867156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.
    Hucke S; Floßdorf J; Grützke B; Dunay IR; Frenzel K; Jungverdorben J; Linnartz B; Mack M; Peitz M; Brüstle O; Kurts C; Klockgether T; Neumann H; Prinz M; Wiendl H; Knolle P; Klotz L
    Brain; 2012 May; 135(Pt 5):1586-605. PubMed ID: 22447120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response.
    Zheng X; Hu X; Zhou G; Lu Z; Qiu W; Bao J; Dai Y
    J Neuroimmunol; 2008 Feb; 194(1-2):107-14. PubMed ID: 18207251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental allergic encephalomyelitis is exacerbated in mice deficient for 12/15-lipoxygenase or 5-lipoxygenase.
    Emerson MR; LeVine SM
    Brain Res; 2004 Sep; 1021(1):140-5. PubMed ID: 15328042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-12/IFN-gamma/NO axis plays critical role in development of Th1-mediated experimental autoimmune encephalomyelitis.
    Xiao BG; Ma CG; Xu LY; Link H; Lu CZ
    Mol Immunol; 2008 Feb; 45(4):1191-6. PubMed ID: 17697713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor delta agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis.
    Kanakasabai S; Chearwae W; Walline CC; Iams W; Adams SM; Bright JJ
    Immunology; 2010 Aug; 130(4):572-88. PubMed ID: 20406305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation.
    Fu YF; Zhu YN; Ni J; Zhong XG; Tang W; Re YD; Shi LP; Wan J; Yang YF; Yuan C; Nan FJ; Lawson BR; Zuo JP
    J Pharmacol Exp Ther; 2006 Nov; 319(2):799-808. PubMed ID: 16914558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice.
    Lu Z; Hu X; Zhu C; Wang D; Zheng X; Liu Q
    J Neuroimmunol; 2009 Jan; 206(1-2):58-69. PubMed ID: 19081144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve growth factor prevents demyelination, cell death and progression of the disease in experimental allergic encephalomyelitis.
    Parvaneh Tafreshi A
    Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):177-81. PubMed ID: 17237570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-21 receptor expression determines the temporal phases of experimental autoimmune encephalomyelitis.
    Liu R; Bai Y; Vollmer TL; Bai XF; Jee Y; Tang YY; Campagnolo DI; Collins M; Young DA; La Cava A; Shi FD
    Exp Neurol; 2008 May; 211(1):14-24. PubMed ID: 18353312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.